The Pharmacogenetic Testing Process begins with the collection of DNA samples for the patient. The data are then analyzed to determine if a patient’s phenotype is associated with any disease-related responses to certain medications. In this article, we will discuss the pathogen research and the pharmacogenetic research process, and how they can be used to improve outcomes.
Pathogen Testing
Table of Contents
Performing this type of study for pathogens is often a helpful way to manage certain diseases. It can help doctors decide on the appropriate course of treatment for patients by determining whether they are genetically predisposed to a specific infection. The test is usually done by obtaining a sample of blood or saliva.
The implication of this type of study for pathogens is important. For example, studies suggest that the apolipoprotein epsilon4 allele predicts the risk of coronary heart disease mortality in elderly Finnish men. However, such studies have raised many ethical questions that warrant more research into their use.
However, a lack of randomized controlled trials has made these studies a challenge. In spite of this, Chang and colleagues recommend the adoption of this type of study for pathogens, assuming that many people will need drug treatment at some point. While point-of-care research is not cost-effective and may be ineffective, prospective research can improve future care.
Pharmacogenetic Testing
This type of study is a powerful tool for doctors and other health professionals, allowing them to use a patient’s genetic makeup to predict drug efficacy and dosage. It is also an important part of personalized medicine, and the FDA has recognized its importance. For example, some genetic variants, such as reduced CYP2C19, are associated with decreased antiplatelet response and increased cardiovascular events following coronary stent procedures.
While genetic testing is highly accurate, family physicians may not know what to do with the results. Companies that specialize in pharmacogenetic testing may be able to provide this service. The process involves a simple, noninvasive cheek swab, followed by DNA analysis. The results of the testing are then used to tailor a medication regimen for a patient.
The process of this type of study is simple and is based on the principle of individualized drug treatment. It begins with a sample of the patient’s saliva, which is sent to a laboratory. The laboratory will create a report detailing possible drug reactions. Depending on a person’s genetic makeup, some drugs may have no effect at all, while others may have side effects.
Actionable Results
Actionable results from pharmacogenetic tests were defined as phenotypes with recommended prescribing changes. However, results can be affected by other factors, including the indication, dosage, and drug interactions. In order to identify those phenotypes that are most likely to affect patient outcomes, actionable pharmacogenetic tests should be conducted in clinical trials.
Despite these limitations, this type of study is an important tool in improving health care.
The purpose of this study was to assess the impact of pharmacogenetic tests on level-A drugs prescribed by veterans in the VA (Veteran Affairs). To do this, we compiled the existing evidence on action ability by gene and medication.
This helped us determine the frequency of actionable pharmacogenetic variants among veterans. Furthermore, we have monitored a number unique veterans who were prescribed level-A medications. Finally, we considered whether actionable results were associated with clinically meaningful changes in prescribing decisions.
These projects have targeted populations, built infrastructure for use of results, and evaluated the benefits of this new approach. In addition to the clinical benefits, we assessed the genetic phenotypes of patients who are likely to benefit from preemptive this type of study. We also assessed the incidence of high-risk drugs among patients and identified the factors that could make this test useful.
Cost
The cost of this type of study can vary widely. You can purchase the test online or at specialized clinics. Prices range from $300 to $1500 CAD, depending on the tests and range of conditions they cover. Pharmacogenetic tests that are proprietary to a single manufacturer tend to cost more than generics.
Because the results of these tests are often controversial, they are generally only used in the most specific clinical situations. When considering the cost of this type of study, you should remember that according to this article, this type of testing is not covered by insurance. Generally, it is available only for a small number of medications and not all insurers cover the cost. You should also check with your insurance provider to determine if it covers the cost.
You may be able to receive a lower premium if your insurance provider covers the cost of this type of study, but this is an expensive option. While this type of study is an important tool in the quest to improve drug therapies and minimize the risk of adverse side effects, it can be costly.
Image Source: BigStockPhoto.com (Licensed)
Related Categories: Health, Reviews
